HealthEquity, Inc.

Equities

HQY

US42226A1079

Software

Market Closed - Nasdaq 04:00:00 2024-02-23 pm EST 5-day change 1st Jan Change
82.23 USD -0.04% Intraday chart for HealthEquity, Inc. +1.16% +24.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Barclays Adjusts HealthEquity's Price Target to $104 From $84, Keeps Overweight Rating MT
Deutsche Bank Adjusts HealthEquity Price Target to $95 From $88, Maintains Buy Rating MT
RBC Raises Price Target on HealthEquity to $90 From $77, Keeps Outperform Rating MT
Transcript : HealthEquity, Inc. - Analyst/Investor Day
HealthEquity Updates Fiscal 2024 Outlook, Affirms 2025 Guidance MT
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025 CI
Transcript : HealthEquity, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 04:30 PM
Healthequity Insider Sold Shares Worth $2,857,721, According to a Recent SEC Filing MT
Healthequity Insider Sold Shares Worth $4,800,046, According to a Recent SEC Filing MT
Deutsche Bank Raises HealthEquity Price Target to $88 From $85, Maintains Buy Rating MT
Wells Fargo Adjusts HealthEquity's Price Target to $93 From $89, Maintains Overweight Rating MT
HealthEquity's Fiscal Q3 Non-GAAP Earnings, Revenue Rise MT
Transcript : HealthEquity, Inc., Q3 2024 Earnings Call, Dec 05, 2023
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 Revenue $249.2M, vs. Street Est of $243.6M MT
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 EPS $0.60, vs. Street Est of $0.50 MT
HealthEquity Guides For FY 2024 EPS of $2.08-$2.16 on Revenue of $985-$995 Million, vs CIQ Analyst Consensus of $2.03/Share on Revenue of $989 Million MT
HealthEquity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025 CI
North American Morning Briefing : China Outlook -2- DJ
Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating MT
Healthequity Insider Sold Shares Worth $143,704, According to a Recent SEC Filing MT
Healthequity Insider Sold Shares Worth $365,923, According to a Recent SEC Filing MT
Healthequity Insider Sold Shares Worth $464,896, According to a Recent SEC Filing MT
North American Morning Briefing : Stock Futures -2- DJ
Baird Upgrades HealthEquity to Outperform From Neutral, Raises Price Target to $87 From $79 MT
Chart HealthEquity, Inc.
More charts
HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
82.23 USD
Average target price
92.59 USD
Spread / Average Target
+12.59%
Consensus
1st Jan change Capi.
+24.03% 7 055 M $
+9.13% 3049 B $
+11.80% 87 811 M $
+11.44% 82 633 M $
-2.05% 61 683 M $
-14.05% 53 033 M $
+33.78% 50 826 M $
+13.17% 39 819 M $
+2.10% 26 216 M $
-9.32% 26 188 M $
Other Software
  1. Stock
  2. Equities
  3. Stock HealthEquity, Inc. - Nasdaq
  4. News HealthEquity, Inc.
  5. Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer